Temozolomide 16571-0819
Product NDC
16571-0819- Manufacturer
- Rising Pharma Holdings, Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- October 4, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA206309
Need to source Temozolomide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Temozolomide | 140 mg/1 |
Drug Class
Alkylating Drug [EPC]Alkylating Activity [MoA]Alkylating Drug [EPC]
Packaging Options(3)
20 CAPSULE in 1 BOTTLE (16571-819-02)
14 CAPSULE in 1 BOTTLE (16571-819-41)
5 CAPSULE in 1 BOTTLE (16571-819-51)